[go: up one dir, main page]

TR200402656T4 - Antikanser ajanları olarak faydalı tiyofen türevleri - Google Patents

Antikanser ajanları olarak faydalı tiyofen türevleri

Info

Publication number
TR200402656T4
TR200402656T4 TR2004/02656T TR200402656T TR200402656T4 TR 200402656 T4 TR200402656 T4 TR 200402656T4 TR 2004/02656 T TR2004/02656 T TR 2004/02656T TR 200402656 T TR200402656 T TR 200402656T TR 200402656 T4 TR200402656 T4 TR 200402656T4
Authority
TR
Turkey
Prior art keywords
anticancer agents
derivatives useful
thiophene derivatives
formula
compounds
Prior art date
Application number
TR2004/02656T
Other languages
English (en)
Inventor
Joseph Luzzio Michael
Arnold Marx Matthew
Bingwei Yang Vera
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200402656T4 publication Critical patent/TR200402656T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Bulus, formül (1) bilesikleri veya bunlarin farmasötik açidan kabul gören bir tuzu ve farmasötik açidan kabul gören tuzlari ve hidratlari ile ilgilidir; buradaki X,Y,R1,R2 ve R11, burada tanimlandigi gibidir. Bulus ayrica formül (1) bilesikleri içeren farmasötik kompozisyonlarla ve bir memelide hiperproliferatif bozukluklarin formül (1) bilesikleri uygulanarak tedavi edilmesine yönelik metotlarla da ilgilidir.
TR2004/02656T 2000-06-06 2001-05-02 Antikanser ajanları olarak faydalı tiyofen türevleri TR200402656T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20968600P 2000-06-06 2000-06-06

Publications (1)

Publication Number Publication Date
TR200402656T4 true TR200402656T4 (tr) 2004-11-22

Family

ID=22779830

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/02656T TR200402656T4 (tr) 2000-06-06 2001-05-02 Antikanser ajanları olarak faydalı tiyofen türevleri

Country Status (22)

Country Link
US (1) US6964961B2 (tr)
EP (1) EP1287001B1 (tr)
JP (1) JP2003535867A (tr)
AR (1) AR032621A1 (tr)
AT (1) ATE277933T1 (tr)
AU (1) AU2001252463A1 (tr)
BR (1) BR0111377A (tr)
CA (1) CA2411084A1 (tr)
DE (1) DE60106022T2 (tr)
DO (1) DOP2001000170A (tr)
EC (1) ECSP014097A (tr)
ES (1) ES2223827T3 (tr)
GT (1) GT200100104A (tr)
MX (1) MXPA02012034A (tr)
PA (1) PA8518701A1 (tr)
PE (1) PE20011373A1 (tr)
PT (1) PT1287001E (tr)
SV (1) SV2002000478A (tr)
TN (1) TNSN01082A1 (tr)
TR (1) TR200402656T4 (tr)
UY (1) UY26750A1 (tr)
WO (1) WO2001094353A1 (tr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4609691B2 (ja) * 1999-07-01 2011-01-12 味の素株式会社 複素環化合物及びその医薬用途
BR0113078A (pt) * 2000-08-09 2003-07-01 Astrazeneca Ab Uso de um composto, composto, processo para a preparação do mesmo, composição farmacêutica, e, método para produzir um efeito antiangiogênico e/ou redutor da permeabilidade vascular em um animal de sangue quente
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
PL371435A1 (en) * 2002-02-01 2005-06-13 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
US7101898B2 (en) 2002-02-01 2006-09-05 Novo Nordisk A/S Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes
CA2478050A1 (en) 2002-03-01 2003-09-12 Pfizer Inc. Indolyl-urea derivatives of thienopyridines useful as anti-angiogenic agents
EP1513516B1 (en) * 2002-06-06 2008-12-03 Boehringer Ingelheim Pharmaceuticals Inc. SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES
UA77303C2 (en) 2002-06-14 2006-11-15 Pfizer Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
US7488823B2 (en) 2003-11-10 2009-02-10 Array Biopharma, Inc. Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
CL2003002287A1 (es) 2002-11-25 2005-01-14 Wyeth Corp COMPUESTOS DERIVADOS DE TIENO[3,2-b]-PIRIDINA-6-CARBONITRILOS Y TIENEO[2,3-b]-PIRIDINA-5-CARBONITRILOS, COMPOSICION FARMACEUTICA, PROCEDIMIENTO DE PREPARACION Y COMPUESTOS INTERMEDIARIOS, Y SU USO EN EL TRATAMIENTO DEL CANCER, APOPLEJIA, OSTEOPOROSIS
US7276519B2 (en) 2002-11-25 2007-10-02 Wyeth Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
CL2004000398A1 (es) 2003-02-27 2005-03-18 Uriach Y Compania S A J Compuestos derivados de pirazolopiridinas, sus sales; procedimiento de preparacion; composicion farmaceutica; y su uso para tratar enfermedades mediadas por quinasas p38, en especial por citocinas, tnf-alfa, il-1, il-6 y/o il-8, tales como enfermedad
US7592352B2 (en) * 2003-05-06 2009-09-22 Smithkline Beecham Corporation Substituted thieno and furo-pyridines
JP4828421B2 (ja) 2003-08-14 2011-11-30 アレイ バイオファーマ、インコーポレイテッド 受容体チロシンキナーゼ阻害剤としてのキナゾリン誘導体
US7501427B2 (en) 2003-08-14 2009-03-10 Array Biopharma, Inc. Quinazoline analogs as receptor tyrosine kinase inhibitors
US7459562B2 (en) 2004-04-23 2008-12-02 Bristol-Myers Squibb Company Monocyclic heterocycles as kinase inhibitors
TW200538453A (en) 2004-04-26 2005-12-01 Bristol Myers Squibb Co Bicyclic heterocycles as kinase inhibitors
US7439246B2 (en) 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US7432373B2 (en) 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7173031B2 (en) 2004-06-28 2007-02-06 Bristol-Myers Squibb Company Pyrrolotriazine kinase inhibitors
CA2573538C (en) 2004-07-30 2014-11-25 Methylgene Inc. Inhibitors of vegf receptor and hgf receptor signaling
AU2006343808B2 (en) 2005-05-20 2012-03-29 Mirati Therapeutics, Inc. Inhibitors of VEGF receptor and HGF receptor signaling
CA2608726C (en) 2005-05-20 2013-07-09 Methylgene Inc. Inhibitors of vegf receptor and hgf receptor signaling
WO2007035428A1 (en) 2005-09-15 2007-03-29 Bristol-Myers Squibb Company Met kinase inhibitors
PE20070619A1 (es) * 2005-09-27 2007-07-02 Wyeth Corp TIENO(2,3-b)PIRIDIN-5-CARBONITRILOS COMO INHIBIDORES DE PROTEINAS QUINASA
US7547782B2 (en) 2005-09-30 2009-06-16 Bristol-Myers Squibb Company Met kinase inhibitors
DK1971601T3 (da) 2005-11-15 2010-02-08 Array Biopharma Inc N4-phenyl-quinazolin-4-aminderivater og beslægtede forbindelser som ERBB Type 1-receptortyrosinkinase-inhibitorer til behandling af hyperproliferative sygdomme
US8003662B2 (en) * 2006-01-30 2011-08-23 Array Biopharma, Inc. Heterobicyclic thiophene compounds and methods of use
EP2137177B1 (en) 2007-04-05 2014-05-07 Amgen, Inc Aurora kinase modulators and method of use
KR20100137495A (ko) 2008-03-05 2010-12-30 메틸진 인코포레이티드 단백질 티로신 키나아제 활성의 억제제
AU2009226024B2 (en) 2008-03-20 2012-07-12 Amgen Inc. Aurora kinase modulators and method of use
WO2010019473A1 (en) 2008-08-14 2010-02-18 Amgen Inc. Aurora kinase modulators and methods of use
MY173229A (en) 2008-11-19 2020-01-07 Forum Pharmaceuticals Inc Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof
RU2011150248A (ru) * 2009-05-11 2013-06-20 Энвиво Фармасьютикалз, Инк. Лечение когнитивных расстройств с определенными рецепторами альфа-7 никотиновой кислоты в комбинации с ингибиторами ацетилхолинэстеразы
PT3029039T (pt) 2010-05-17 2017-11-28 Forum Pharmaceuticals Inc Formulações farmacêuticas que compreendem formas cristalinas de cloridrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo(b)tiofeno-2-carboxamida mono-hidratado
EP2846796A4 (en) 2012-05-08 2015-10-21 Forum Pharmaceuticals Inc METHODS OF MAINTAINING, PROCESSING OR ENHANCING COGNITIVE FUNCTION
FR3080620B1 (fr) * 2018-04-27 2021-11-12 Univ Paris Sud Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices
CN113648307B (zh) * 2021-09-23 2022-09-30 河南大学 MII-tt-DTT及其在制备抗结直肠癌药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3277623D1 (en) 1981-07-31 1987-12-17 Sloan Kettering Inst Cancer Anti-leukemic beta-glycosyl c-nucleosides
US5124331A (en) 1988-03-02 1992-06-23 Yoshitomi Pharmaceutical Industries, Ltd. 3,4-dihydrothieno[2,3-d]pyrimidine compounds and their pharmaceutical use
JPH02256667A (ja) * 1988-12-27 1990-10-17 Masatoshi Yamato 縮合キノリン系化合物およびその製造方法
AU651337B2 (en) 1990-03-30 1994-07-21 Dowelanco Thienopyrimidine derivatives
US5187168A (en) 1991-10-24 1993-02-16 American Home Products Corporation Substituted quinazolines as angiotensin II antagonists
CA2129337A1 (en) 1992-02-19 1993-09-02 Jotham W. Coe Heterocyclic compounds for enhancing antitumor activity
US5679683A (en) 1994-01-25 1997-10-21 Warner-Lambert Company Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
IL112249A (en) 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
DK0831829T3 (da) 1995-06-07 2003-12-15 Pfizer Heterocykliske, ringkondenserede pyrimidinderivater
AR004010A1 (es) 1995-10-11 1998-09-30 Glaxo Group Ltd Compuestos heterociclicos
EP0778277B1 (en) 1995-12-08 2003-06-25 Pfizer Inc. Substituted heterocyclic derivatives as CRF antagonists
PT882051E (pt) 1996-02-07 2002-04-29 Janssen Pharmaceutica Nv Tiofenopirimidinas
KR20000057228A (ko) 1996-11-27 2000-09-15 디. 제이. 우드, 스피겔 알렌 제이 축합된 비사이클릭 피리미딘 유도체
ZA986729B (en) * 1997-07-29 1999-02-02 Warner Lambert Co Irreversible inhibitors of tyrosine kinases
ID23978A (id) * 1997-11-11 2000-06-14 Pfizer Prod Inc Turunan-turunan tienopirimidin dan tienopiridin yang berguna sebagai zat-zat anti kangker

Also Published As

Publication number Publication date
ATE277933T1 (de) 2004-10-15
ECSP014097A (es) 2003-02-06
PA8518701A1 (es) 2002-09-17
US20020042409A1 (en) 2002-04-11
MXPA02012034A (es) 2003-04-25
CA2411084A1 (en) 2001-12-13
TNSN01082A1 (fr) 2005-11-10
BR0111377A (pt) 2003-06-03
DE60106022D1 (de) 2004-11-04
JP2003535867A (ja) 2003-12-02
DOP2001000170A (es) 2002-05-15
WO2001094353A1 (en) 2001-12-13
EP1287001B1 (en) 2004-09-29
GT200100104A (es) 2002-01-31
PE20011373A1 (es) 2002-01-18
US6964961B2 (en) 2005-11-15
SV2002000478A (es) 2002-07-03
PT1287001E (pt) 2004-12-31
EP1287001A1 (en) 2003-03-05
UY26750A1 (es) 2002-01-31
DE60106022T2 (de) 2006-03-09
AU2001252463A1 (en) 2001-12-17
ES2223827T3 (es) 2005-03-01
AR032621A1 (es) 2003-11-19

Similar Documents

Publication Publication Date Title
TR200402656T4 (tr) Antikanser ajanları olarak faydalı tiyofen türevleri
MY132073A (en) Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
CA2510853A1 (en) Pyrrolopyrimidine derivatives
NO20060973L (no) Pyridylderivater og deres anvendelse som tempeutiske midler
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
WO2005011657A3 (en) Piperazine derivatives and their use as therapeutic agents
TR200003478T2 (tr) Antikanser maddeleri olarak faydalı izotiyazol türevleri
DK0928788T3 (da) Imidazolidin-4-on-derivater, der er nyttige som anticancer-midler
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
PT1294402E (pt) Compostos com um grupo sulfonamida e composicoes farmaceuticas contendo estes compostos
WO2003074529A3 (en) iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
DE69709493D1 (de) Substituierte Indazolderivate
PT992509E (pt) Novos derivados macrolidos
EP1434762A4 (en) 4'-METHANSULFONYLBIPHENYL DERIVATIVES AS HIGH-DETECTIVE CYCLOOXYGENASE-2 INHIBITORS
TR200102306T2 (tr) Faktör Xa önleyici olarak heterosiklik türevler.
AP2002002595A0 (en) Heterocyclic amide derivatives.
ATE248165T1 (de) Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
EP2266566A3 (en) Nicotinamide derivatives and their use as therapeutic agents
DE69908855D1 (de) 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin
NO20020668D0 (no) Ascidideminderivater og deres terapeutiske anvendelser